‘Genetic Testing Saved My Life’ — Joanna Gutermuth’s Ovarian Cancer Story June 3, 2020By Constance Costas
Hope For Newly Diagnosed Ovarian Cancer Patients – PARP Inhibitors Now FDA-Approved For Front-Line Ovarian Cancer Treatment May 21, 2020By Irla Belli
Two Major New Ovarian Cancer Approvals — Expanding Access To PARP Inhibitors May 11, 2020By Laura Gesualdi
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) November 19, 2019By
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers August 26, 2019By
